Zostavax | European Medicines Agency
www.ema.europa.eu › en › medicinesJul 1, 2022 · Zostavax is indicated for prevention of herpes zoster ('zoster' or shingles) and herpes-zoster-related post-herpetic neuralgia. Zostavax is indicated for immunisation of individuals 50 years of age or older. Assessment history Changes since initial authorisation of medicine
Zoster vaccine - Wikipedia
en.wikipedia.org › wiki › Zoster_vaccineA zoster vaccine is a vaccine that reduces the incidence of herpes zoster (shingles), a disease caused by reactivation of the varicella zoster virus, which is also responsible for chickenpox. [7] Shingles provokes a painful rash with blisters, and can be followed by chronic pain ( postherpetic neuralgia ), as well as other complications.